Skip to content

PROCEPT BioRobotics Corporation PRCT Additional Paid-In Capital

Additional Paid-In Capital at other companies

TFX
TeleflexTFX
$815.81M+4.4%
Absci Corporation logo
Absci CorporationABSI
$826.04M+12.4%
UFP Technologies logo
UFP TechnologiesUFPT
$45.09M+14.6%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$3.9B+1.2%
iRadimed logo
iRadimedIRMD
$31.02M+0.9%
Novanta logo
NovantaNOVT
$556.41M+609%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's additional paid-in capital?
PROCEPT BioRobotics Corporation (PRCT) reported additional paid-in capital of $1.02B in Q1 2026.
How has PROCEPT BioRobotics Corporation's additional paid-in capital changed year-over-year?
PROCEPT BioRobotics Corporation's additional paid-in capital increased by 6.4% year-over-year, from $959.66M to $1.02B.
What is the long-term trend for PROCEPT BioRobotics Corporation's additional paid-in capital?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's additional paid-in capital has grown at a 121.7% compound annual growth rate (CAGR), from $18.79M to $1.01B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.